Rainmed Medical Limited (HKG:2297)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.285
-0.005 (-1.72%)
Mar 10, 2026, 2:48 PM HKT
87.50%
Market Cap 406.39M
Revenue (ttm) 25.60M
Net Income (ttm) -113.98M
Shares Out 1.40B
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 192,000
Average Volume 780,850
Open 0.275
Previous Close 0.290
Day's Range 0.275 - 0.285
52-Week Range 0.147 - 0.530
Beta 0.73
RSI 50.67
Earnings Date Mar 27, 2026

About Rainmed Medical

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2014
Employees 214
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2297
Full Company Profile

Financial Performance

In 2024, Rainmed Medical's revenue was 39.82 million, a decrease of -45.61% compared to the previous year's 73.22 million. Losses were -113.50 million, -2.02% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.